Most people take it in the morning or evening consistently, rather than timing it around workouts
Since acarbose is a prescription medication, some individuals who wish to use it to control post-meal glucose elevations but are not diabetic may have difficulty obtaining the drug
Phase 3 outcomes (2026): TRIUMPH-1 (May 2026, n=2,339) demonstrated 28.3% mean weight loss at 12mg weekly the largest published Phase 3 result of any GLP-1 class compound to date, exceeding tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints
For many others, it isn't - and they end up quitting before results ever show up
In a specific case, after being placed in a portable hyperbaric chamber and having the oxygen delivery rate reduced from 3 L/min to 0.5 L/min for ~8 h, the patient experienced some relief of symptoms but ultimately required helicopter evacuation to the nearest hospital for further care